Hematology blood test

DIAGNOSTIC_TEST2 trials

Sponsors

MGC Pharmaceuticals d.o.o

Conditions

Corona Virus InfectionCovid19SARS-CoV Infection

Phase 2

Study Designed to Evaluate the Effect of CimetrA in Patients Diagnosed With COVID-19

CompletedNCT05037162

MGC Pharmaceuticals d.o.oCorona Virus Infection, Covid19

Start: 2022-10-11End: 2023-03-01Updated: 2023-03-15

Phase 3

Clinical Study Designed to Evaluate the Effect of CimetrA in Patients Diagnosed With COVID-19

MGC Pharmaceuticals d.o.oCorona Virus Infection, Covid19, SARS-CoV Infection

Start: 2021-06-11End: 2023-04-30Target: 252Updated: 2022-08-24